α1,4‐Linked N ‐acetylglucosamine suppresses gastric cancer development by inhibiting Mucin‐1‐mediated signaling
Open Access
- 31 August 2022
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 113 (11) , 3852-3863
Abstract
Gastric cancer is the second leading cause of cancer deaths worldwide, and more understanding of its molecular basis is urgently needed. Gastric gland mucin secreted from pyloric gland cells, mucous neck cells, and cardiac gland cells of the gastric mucosa harbors unique O-glycans carrying terminal alpha 1,4-linked N-acetylglucosamine (alpha GlcNAc) residues. We previously reported that alpha GlcNAc loss correlated positively with poor outcomes for patients with differentiated-type gastric cancer. However, the molecular mechanisms underlying these outcomes remained poorly understood. Here, we examined the effects of upregulated alpha GlcNAc expression on malignant phenotypes of the differentiated-type gastric cancer cell lines, AGS and MKN7. Upregulation of alpha GlcNAc following ectopic expression of its biosynthetic enzyme attenuated cell proliferation, motility, and invasiveness of AGS and MKN7 cells in vitro. Moreover, AGS cell tumorigenicity was significantly suppressed by alpha GlcNAc overexpression in a xenograft model. To define the molecular mechanisms underlying these phenotypes, we investigated alpha GlcNAc binding proteins in AGS cells and identified Mucin-1 (MUC1) and podocalyxin. Both proteins were colocalized with alpha GlcNAc on human gastric cancer cells. We also found that alpha GlcNAc was bound to MUC1 in murine normal gastric mucosa. When we assessed the effects of alpha GlcNAc binding to MUC1, we found that alpha GlcNAc blocked galectin-3 binding to MUC1, phosphorylation of the MUC1 C-terminus, and recruitment of Src and beta-catenin to that C-terminus. These results suggest that alpha GlcNAc regulates cancer cell phenotypes by dampening MUC1 signal transduction.Keywords
Funding Information
- Japan Society for the Promotion of Science (18K08613, 19H03441)
This publication has 34 references indexed in Scilit:
- MUC4 and MUC1 Expression in Adenocarcinoma of the Stomach Correlates with Vessel Invasion and Lymph Node Metastasis: An Immunohistochemical Study of Early Gastric CancerPLOS ONE, 2012
- Essential role of gastric gland mucin in preventing gastric cancer in miceJournal of Clinical Investigation, 2012
- Mucin-interacting proteins: from function to therapeuticsTrends in Biochemical Sciences, 2010
- A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancerCancer Causes & Control, 2009
- Sensitive Liquid Chromatography-Electrospray Mass Spectrometry Allows for the Analysis of the O-Glycosylation of Immunoprecipitated Proteins from Cells or Tissues: Application to MUC1 Glycosylation in CancerJournal of Proteome Research, 2008
- Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesisOncogene, 2005
- MUC1 alters β-catenin-dependent tumor formation and promotes cellular invasionOncogene, 2003
- Immunohistochemical Demonstration of α1,4-N-acetylglucosaminyltransferase that Forms GlcNAcα1,4Galβ Residues in Human Gastrointestinal MucosaJournal of Histochemistry & Cytochemistry, 2001
- The c-Src Tyrosine Kinase Regulates Signaling of the Human DF3/MUC1 Carcinoma-associated Antigen with GSK3β and β-CateninJournal of Biological Chemistry, 2001
- Expression cloning of a human α1,4-N-acetylglucosaminyltransferase that forms GlcNAcα1→4Galβ→R, a glycan specifically expressed in the gastric gland mucous cell-type mucinProceedings of the National Academy of Sciences, 1999